MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 25.04.2026
Immutep Limited P/CF 2011-2026 | IMMP
P/CF Jährlich Immutep Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -111 | -11.6 | -3.8 | -6.21 | -4.22 | -6.16 | -8.31 | -3.2 | -6.98 | -7.11 | - |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -3.2 | -111 | -16.8 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-1.79 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
-1.63 | $ 1.61 | 2.55 % | $ 189 M | USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | France |
 |
BioNTech SE
BNTX
|
48.3 | $ 92.14 | 1.33 % | $ 22.3 B | Germany |
 |
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-30.2 | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
6.2 | $ 2.8 | 7.28 % | $ 262 M | Israel |
 |
Abcam plc
ABCM
|
172 | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-117 | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
-4.21 | $ 0.72 | -0.37 % | $ 32.9 M | Israel |
 |
Affimed N.V.
AFMD
|
-6.09 | - | -34.95 % | $ 21.5 M | Germany |
 |
Esperion Therapeutics
ESPR
|
-42.9 | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
53.1 | $ 32.59 | -6.89 % | $ 877 M | USA |
|
Forte Biosciences
FBRX
|
-6.59 | $ 21.59 | -1.86 % | $ 280 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
-0.379 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
-3.39 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-0.195 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-2.88 | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-3.33 | - | - | $ 384 M | Britain |
 |
Gracell Biotechnologies
GRCL
|
-6.52 | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
19.1 | $ 14.88 | -0.93 % | $ 213 M | USA |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
 |
InflaRx N.V.
IFRX
|
-1.79 | $ 2.61 | 5.67 % | $ 176 M | Germany |
 |
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.205 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.4 | -1.16 % | $ 5.6 M | Israel |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
-5.09 | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | USA |
 |
Immuron Limited
IMRN
|
-37.6 | $ 1.0 | 2.04 % | $ 231 M |  Australia |